Stockrabit · Analysts
Questions across 6 calls

Sumeet Jain

CLSA

Netweb Technologies India Limited

Netweb Technologies India Limited CC-Nov25.pdf · 2025-11-03
So firstly, I wanted to check around your R&D cost. I mean, do you disclose your R&D cost as a percentage of sales? And in terms of number of patents being filed this year compared to last year, given you have mentioned that a lot of your solutions are pure tech led with a lot of software and hardware design? So just limps of R&D costs and patent filings?
Got it. That's helpful. Secondly, I wanted to check around your market share in the 3, 4 segments you highlighted in your investor deck, and you have also given the overall market sizing in each one of them. And it seems like your market share is in single digits in each of those categories. Since we don't get any overall market share data or anything in any of these categories, can you briefly flag, I mean, are you gaining market share, losing market share or it's largely stable?

LTM Limited

HCL Technologies Limited

HCL Technologies Limited CC-Mar25.pdf · 2025-04-22
Hi, thanks for the opportunity. Firstly, just wanted to understand what is the organic growth guidance for FY26 given that the HP E asset acquisition closed on 2nd December and in this quarter you had a significant increase in your telecom vertical on the back of it. But there will be practically a nine -month impact or eight-month impact in next year of this acquisition.
Got it. And secondly, in your ER&D side, I mean, we can see very strong growth in this quarter. And you also mentioned that order booking had a 75% growth in FY25. So can you just highlight what's happening in your ER&D business? Because generally, when we look at the automotive or the Manufacturing space, and ER&D is considered to be discretionary in nature. So what is the difference what you are seeing in your end markets?

Tata Consultancy Services Limited

Tata Consultancy Services Limited CC-Dec24.pdf · 2025-01-09
Happy New Year to entire management. Krithi, I think you mentioned that you are seeing early signs of revival and discretionary spend across various verticals due to political uncertainty being behind in US. But if you look, there is still a lot of uncertainty around potential increase in inflation due to trade tariffs or uncertain government policies or increase in the US interest rates, which we are seeing in the current US bond yields. So how stable is this revival in the discretionary spend you're expecting probably over the next 1 quarter to 2 quarters and the entire CY '25?
Got it. That's helpful. And maybe can you also comment around health care, Life Sciences and manufacturing verticals. I was not very clear, are you saying that they have already bottomed out and they will start seeing growth from next quarter onwards or are you still waiting for some clarity there?

Wipro Limited

Wipro Limited CC-Sep24.pdf · 2024-10-17
So, firstly, Srini, Aparna, I wanted to know from you in this guidance of -2 to 0%, what are you building for BFSI next quarter? Are you still building in growth momentum to continue, but given it has high furloughs, but you are seeing a strong momentum?
I just wanted to understand how long this decline in Manufacturing and E&U, the energy utility verticals will continue given that for the last 7 -8 quarters now it has been declining. So, the ramp down in the client specific areas should have been over by now. So, is it like a structural problem we are facing in these two verticals? Because when I look at Manufacturing, particularly, it has seen very strong growth for most of our peers plus the SAP S/4 HANA transformation is a big opportunity, which you also mentioned is playing out in your logistics client, so I just want to unde rstand how Manufacturing E&U will play out, let us say over the next 6 -12 months, forgetting about just next quarter?